Gallbladder cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of gallbladder cancer, 2015-2017, UK.

Deaths

Deaths from gallbladder cancer, 2015-2017, UK.

Survival

Survive gallbladder cancer for 10 or more years, 2009-2013, England

 

Preventable cases

Preventable cases of gallbladder cancer, UK

  • There are around 1,100 new gallbladder cancer cases in the UK every year, that's around 3 every day (2015-2017).
  • Gallbladder cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).
  • In females in the UK, gallbladder cancer is not among the 20 most common cancers, with around 770 new cases in 2017.
  • In males in the UK, gallbladder cancer is not among the 20 most common cancers, with around 310 new cases in 2017.
  • Incidence rates for gallbladder cancer in the UK are highest in people aged 85 to 89 (2015-2017).
  • Each year more than half (52%) of all new gallbladder cancer cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, gallbladder cancer incidence rates have increased by more than three-fifths (62%) in the UK. Rates in females have increased by more than seven-tenths (72%) and rates in males have increased by around half (49%) (2015-2017).
  • Over the last decade, gallbladder cancer incidence rates have increased by almost half (48%) in the UK. Rates in females have increased by around half (51%), and rates in males have increased by almost half (46%) (2015-2017).
  • An estimated 3,600 people who had previously been diagnosed with gallbladder cancer were alive in the UK at the end of 2010.

See more in-depth gallbladder cancer incidence statistics

  • There are around 590 gallbladder cancer deaths in the UK every year, that's more than 1 every day (2015-2017).
  • Gallbladder cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2017).
  • In females in the UK, gallbladder cancer is not among the 20 most common causes of cancer death, with around 420 deaths in 2017.
  • In males in the UK, gallbladder cancer is not among the 20 most common causes of cancer death, with around 180 deaths in 2017.
  • Mortality rates for gallbladder cancer in the UK are highest in people aged 85 to 89 (2015-2017).
  • Since the early 1970s, gallbladder cancer mortality rates have decreased by around two-fifths (41%) in the UK. Rates in females have decreased by more than a third (36%), and rates in males have decreased by more than two-fifths (44%).
  • Over the last decade, gallbladder cancer mortality rates have increased by a sixth (17%) in the UK. Rates in females have increased by a fifth (20%), and rates in rates in males have remained stable.

See more in-depth gallbladder cancer mortality statistics

  • 3 in 20 (15%) people diagnosed with gallbladder cancer in England survive their disease for ten years or more (2009-2013).
  • More than 3 in 20 (17%) people diagnosed with gallbladder cancer in England survive their disease for five years or more (2009-2013).
  • More than 4 in 10 (43%) people diagnosed with gallbladder cancer in England survive their disease for one year or more (2009-2013).
  • Gallbladder cancer 10-year survival in England is similar in men and women (2009-2013).
  • Gallbladder cancer survival in England is highest for adults diagnosed aged under 50 years old (2009-2013).
  • Around 4 in 10 people in England diagnosed with gallbladder cancer aged 15-49 survive their disease for five years or more, compared with more than a tenth of people diagnosed aged 70-89 (2009-2013).
  • Five-year relative survival for gallbladder cancer in men is similar to the European average in England, Wales and Scotland.
  • Five-year relative survival for gallbladder cancer in women is similar to the European average in England.

See more in-depth gallbladder cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 947 UK males and 1 in 419 UK females will be diagnosed with gallbladder cancer in their lifetime.
  • 20% of gallbladder cancer cases in the UK are preventable.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.

See more in-depth gallbladder cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.